As the HY and LB subgroups have previously been found to have a more favourable prognosis [43], the enrichment of MM patients with reduced GLIPR1 expression in these subgroups is consistent with our finding that GLIPR1 expression does not impact on overall survival. This evidence concerns the gene GLIPR1 and Miyoshi myopathy.